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Abstract
Background: Male Irs2-/- mice develop fatal type 2 diabetes at 13-14 weeks. Defects in neuronal proliferation, pituitary 
development and photoreceptor cell survival manifest in Irs2-/- mice. We identify retarded renal growth in male and 
female Irs2-/- mice, independent of diabetes.
Results: Kidney size and kidney:body weight ratio were reduced by approximately 20% in Irs2-/- mice at postnatal day 5 
and was maintained in maturity. Reduced glomerular number but similar glomerular density was detected in Irs2-/- 
kidney compared to wild-type, suggesting intact global kidney structure. Analysis of insulin signalling revealed renal-
specific upregulation of PKBβ/Akt2, hyperphosphorylation of GSK3β and concomitant accumulation of β-catenin in 
Irs2-/- kidney. Despite this, no significant upregulation of β-catenin targets was detected. Kidney-specific increases in 
Yes-associated protein (YAP), a key driver of organ size were also detected in the absence of Irs2. YAP phosphorylation 
on its inhibitory site Ser127 was also increased, with no change in the levels of YAP-regulated genes, suggesting that 
overall YAP activity was not increased in Irs2-/- kidney.
Conclusions: In summary, deletion of Irs2 causes reduced kidney size early in mouse development. Compensatory 
mechanisms such as increased β-catenin and YAP levels failed to overcome this developmental defect. These data 
point to Irs2 as an important novel mediator of kidney size.
Background
The insulin receptor substrate (IRS) family of proteins
plays a key role in insulin signalling [1]. Most, if not all,
insulin signals are modulated through tyrosine phospho-
rylation of IRS proteins [2]. IRS proteins are intermediate
cellular scaffold proteins, which act as an interface
between tyrosine kinase receptors and effector proteins
such as PI3K and MAPK. The crucial role of IRS proteins
in insulin action has been demonstrated using knockout
mouse models [3]. The distinct phenotypes of Irs1-/- and
Irs2-/- mice present a fascinating physiological contrast,
despite the significant structural similarities of these pro-
teins [4]. Irs1-/- mice are approximately 50% smaller in
size compared to littermate controls, highlighting the
importance of IRS1 in somatic growth promotion [5-7].
Irs1-/- mice are insulin resistant but also maintain normal
fasting glucose and glucose tolerance due to compensa-
tory β-cell hyperplasia [5,6]. In contrast, mice lacking Irs2
develop type 2 diabetes, with Irs2-/- male mice displaying
both insulin resistance and β-cell failure at an early age
[8,9]. In light of their pivotal role in insulin signalling, IRS
proteins have been examined as candidate genes for type
2 diabetes and other human metabolic disorders [1].
Animal and organ size is determined by hormones and
growth factors that control processes such as cell number,
cell size and cell death during fetal development and
postnatal growth [10-12]. The important role of the insu-
lin/IGF-1 signalling pathway in growth and development
is well established. Ablation of insulin and IGF-1 recep-
tors results in early postnatal death [13-15]. IRS2 does
not regulate somatic growth to the same extent as IRS1,
and Irs2-/- mice were only 10% smaller in size compared
to wild-type controls [7]. However, Irs2  gene deletion
precipitates a number of pathophysiological effects in
organs that are typically affected by diabetic complica-
tions. In the retina, Irs2 deletion in mice caused increased
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photoreceptor cell apoptosis, with decreased maturation
and survival of photoreceptors [16]. Irs2-/- mice also dis-
play reduced neuronal proliferation, leading to reduced
brain size [17]. In the kidney, insulin is known to modify
several functions of renal tubules [18-23], with IRS2 play-
ing a major role in insulin stimulation of renal proximal
tubular transport and PKB/Akt phosphorylation in vitro
[24]. Since insulin-like, and other growth factor signalling
is crucial in organ development [25], we examined the
effect of Irs2 gene deletion on kidney function and devel-
opment in mice. Our data highlight a novel role for IRS2
signalling in kidney size development and insulin signal-
ling in renal cells.
Results
IRS2 is expressed in mouse kidney
Levels of IRS2 mRNA were high in mouse kidney com-
pared to mouse liver (Fig. 1A, B). IRS2 protein was
detected in wild-type and Irs2+/- kidney, but not in Irs2-/-
kidney extracts (Fig. 1C). A modest 2-fold increase in
IRS1 mRNA levels was detected in Irs2-/- kidney, suggest-
ing a mild compensatory increase in IRS1 in the absence
of IRS2 (Additional File 1 Fig. S1).
Deletion of Irs2 causes decreased kidney size in mice
Both kidney weight and kidney-to-body weight ratio were
reduced in Irs2-/- mice at 5-6 wk of age, in both male and
female mice (Fig. 2 and Additional File 1 Table S1). Kid-
ney size was clearly smaller in Irs2-/- mice compared to
wild-type at various time-points (Fig. 3A, B and Addi-
tional File 1 Fig. S2). Newborn Irs2-/- mice displayed a
reduction in kidney-to-body weight ratio at 5 d of age
(wild-type 5.411 +/- 0.115, Irs2-/- 4.364 +/- 0.2, p < 0.001)
which was maintained up to 25 d and beyond (Fig. 3C).
The slopes of the growth curves indicated that Irs2-/- mice
had a higher rate of growth between 5 d and 12 d com-
Figure 1 IRS2 is detected in mammalian kidney. Semi-quantitative 
(A) and quantitative TaqMan (B) PCR was performed using RNA from 
renal poles of 5-6 wk Irs2+/+ (empty bars), Irs2+/- (striped bars) and Irs2-/- 
mice (filled bars) and Irs2 specific oligonucleotides as described in Ma-
terial and Methods. ΔΔCt values were calculated by subtracting the Ct 
values for IRS2 by those for the 18S control performed simultaneously, 
and fold change was then calculated by setting the wild-type liver 
group value to 1. Data are expressed as mean +/- SEM, n = 5 for each 
group. Statistical significance was determined using one way ANOVA 
with post hoc Tukey-Kramer multiple comparisons test, *** p < 0.001. 
(C) Immunoprecipitation was carried out on 1 mg protein lysates from 
Irs2+/+, Irs2+/- and Irs2-/- kidney. Protein lysates were separated on 7.5% 
SDS-PAGE and probed by Western blotting with anti-IRS2 antibody.
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body weight ratios were calculated for Irs2+/+ (open squares), Irs2+/- 
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pared to wild-type or Irs2+/- (Irs2+/+ slope 0.0189, Irs2-/-
slope 0.0605). However, the growth rate was similar
between 12 d and 25 d in all three genotypes, suggesting
that this higher rate of growth was not maintained in Irs2-
/- mice. Supporting this observation, kidney size in older
female mice (43-44 wk) remained smaller in Irs2-/- mice
compared to wild-type (data not shown), suggesting that
the initial defect in kidney growth is not overcome during
the lifetime of the Irs2-/- mouse. No significant histologi-
cal changes were seen in Irs2-/- kidneys compared to wild-
type at any age group, using a range of specific stains for
markers of kidney damage (Additional File 1 Fig. S3).
Quantitation of glomeruli in H&E stained paraffin sec-
tions revealed that Irs2-/- kidneys contained less glomeruli
per kidney section than wild-type (Irs2-/- 200+/- 29
glomeruli per section, wild-type 217+/- 25 glomeruli per
section). However, when normalised for sectional area, a
similar density of glomeruli (and by inference, nephrons)
was present in Irs2-/- kidneys compared to wild-type
mice (Additional File 1 Fig. S4). Together, these data sug-
gest that Irs2  deletion leads to a global reduction in
mouse kidney size during development.
Irs2 deletion causes increased PKB/Akt signalling 
specifically in kidney
PKB/Akt activation is a key regulator of glomerular pod-
ocyte and tubular epithelial cell survival [26-29]. The sta-
tus of PKB/Akt expression was therefore assessed in
kidneys of wild-type, Irs2+/- and Irs2-/- kidneys. Surpris-
ingly, levels of total PKB/Akt were elevated in both male
and female Irs2-/- kidneys at 5-6 wk of age compared to
wild-type and Irs2+/- (Fig. 4). This 2.5-3-fold increase in
PKB/Akt expression was also maintained in older mice
(data not shown). Using isoform specific antibodies,
marked upregulation of PKBβ/Akt2 was identified in Irs2-
/-  mouse kidney compared to controls (Fig. 5). This
increase was not observed in Irs2-/- liver or brain (data not
shown), suggesting that upregulation of PKBβ/Akt2 may
be specific to Irs2-/- mouse kidney. No change in the level
of mRNA for all three PKB/Akt isoforms was detected in
Irs2-/- kidney compared to wild-type or Irs2+/-, suggesting
that either increased PKBβ/Akt2 translation or post-tran-
scriptional stability may account for the observed protein
increase in kidney in the absence of Irs2.
To explore whether defects in growth factor signalling
contribute to decreased kidney size in Irs2-/- mice, the
activation of PKB/Akt in kidney in response to insulin
was assessed. Insulin stimulated PKB/Akt phosphoryla-
tion in both wild-type and Irs2-/- kidney (Fig. 6A-C). Lev-
els of basal PKB/Akt Thr308 and Ser473 phosphorylation
also appeared to be higher in Irs2-/- kidney compared to
wild-type (Fig. 6). Insulin injection triggered a higher
degree of PKB/Akt phosphorylation on Thr308 in Irs2-/-
k i d n ey  c o m p a r e d  t o  w i l d -t ype ,  w h e r e as  f o l d - c h a n g e  o f
Ser473 phosphorylation was similar between the two
genotypes (Fig. 6). These data suggest that PKB/Akt acti-
vation may be increased in the absence of IRS2 in kidney.
The effect of increased PKBβ/Akt2 expression on the
phosphorylation of GSK3β, a major downstream target of
PKB/Akt was then assessed. Phosphorylation of GSK3β
on the inhibitory Ser9 site increased in both wild-type
and Irs2-/- kidney in response to insulin (Fig. 7A). How-
Figure 4 Increased PKB/Akt expression in Irs2-/- mouse kidney. 
Twenty μg of kidney protein lysates from 5-6 wk Irs2+/+, Irs2+/- and Irs2-
/- 5-6 wk male (A) and female (B) groups were separated on 10% SDS-
PAGE and probed by Western blotting with anti-PKB/Akt. GAPDH was 
used as a loading control. Band intensities were calculated using Scion 
Image software. The intensity ratios of PKB/GAPDH are shown. ** p < 
0.01.
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Figure 5 Specific increase in PKBβ/Akt2 is detected in Irs2-/- kid-
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and Irs2-/- (n = 6) mice were separated on 10% SDS-PAGE and probed 
by Western blotting with anti-PKBα/Akt1, PKBβ/Akt2, PKBγ/Akt3 and 
anti-PKB/Akt antibodies. GAPDH was used as a loading control. (B) 
Band intensities were quantified using Scion Image software. The in-
tensity ratio of anti-PKBβ/GAPDH is shown. ** p < 0.01.
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ever, a number of additional bands were detected with
both phospho- and total GSK3β antibodies in Irs2-/- kid-
ney extracts compared to wild-type, in both vehicle and
insulin-stimulated mice (Fig. 7A). These data suggest that
increased PKB/Akt activation triggers hyperphosphory-
lation and inactivation of GSK3β in kidney. Consistent
with this hypothesis, levels of β-catenin, a protein tar-
geted by GSK3β for degradation, were markedly elevated
in Irs2-/- kidney compared to controls (Fig. 7B, C). How-
ever, despite increased accumulation of β-catenin, no
major changes in the expression of β-catenin targets c-
myc, c-jun and cyclin D1 were evident in Irs2-/- kidneys
(Fig. 7D).
Deletion of Irs2 causes kidney-specific increases in YAP 
expression and phosphorylation
The Hippo-YAP pathway has shown to be crucial in cellu-
lar processes that increase mammalian organ size [30-32].
YAP is a transcriptional co-activator that is phosphory-
lated by kinase cascades such as Hippo/Mst1, leading to
cytoplasmic localisation and inhibition of transcription
[32,33]. Levels of total YAP were almost undetectable in
kidney extracts of adult wild-type mice, but were signifi-
cantly elevated in Irs2-/- kidney compared to controls (Fig.
8A). Importantly, levels of YAP phosphorylation on the
inhibitory site Ser127 were also increased in the absence
of Irs2 (Fig. 8A). Previous data have suggested that PKB/
Akt may phosphorylate YAP, inhibiting its function [33].
In our study, insulin treatment had little effect on YAP
phosphorylation in either wild-type and Irs2-/-  kidney
(Fig. 8B). No changes in YAP levels or phosphorylation
were detected in other mouse tissues (data not shown).
These data suggest that deletion of Irs2 causes increased
expression of the transcriptional co-activator YAP in kid-
ney, which is immediately inactivated by phosphoryla-
tion, preventing potential YAP-induced increases in
kidney size.
Discussion
IRS2 is a fundamental element in normal insulin and
IGF-1 signalling, regulating glucose metabolism, brain
growth, ovarian development and retinal photoreceptor
Figure 6 Increased insulin-stimulated PKB/Akt activation in Irs2-/
- kidney. (A) Twenty μg of kidney lysates from vehicle ("-") and insu-
lin("+") -injected 5-6 wk Irs2+/+ and Irs2-/- mice were separated on 10% 
SDS-PAGE and probed by Western blotting with anti-phospho-PKB/
Akt Thr308, anti-phospho-PKB/Akt Ser473 and anti-PKB/Akt. GAPDH 
was used as a loading control. (B, C) Band intensities were quantified 
using Scion Image software. The intensity ratio of pThr308/GAPDH and 
pSer473/GAPDH are shown. * p < 0.05, ** p < 0.01, ***p < 0.001.
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Figure 7 Altered GSK3β/β-catenin signalling is evident in Irs2-/- 
mouse kidney. (A). Twenty μg of kidney protein lysates from Irs2+/+ 
and Irs2-/- mice injected with insulin were probed by Western blotting 
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from female Irs2+/+ (n = 3), Irs2+/- (n = 3) and Irs2-/- (n = 6) mice were 
probed with the indicated antibodies. GAPDH was used as loading 
control. (C) Band intensities were quantified using Scion Image soft-
ware. The intensity ratio of β-catenin/GAPDH is shown. p *< 0.05. (D) 
Twenty μg of kidney protein lysates from Irs2+/+ (n = 3), Irs2+/- (n = 3) 
and Irs2-/- (n = 6) mice were probed with anti-c-myc and anti-cyclin D1 
antibodies.
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apoptosis [7,9,16,17,34]. Defects in insulin signalling may
contribute to diabetic kidney disease [25]. Our data iden-
tify a novel role for IRS2 in renal development and in the
regulation of PKB/Akt/GSK3β and Hippo/YAP signalling
in the kidney.
Defects in organ growth and development have been
reported due to Irs2  gene deletion [16,17], with IRS1
playing a more dominant role in somatic growth com-
pared to IRS2 [5-7]. Expression of IRS2 can be detected in
renal cortex at E14.5, with minimal IRS1 and IRS3 dete-
cetd at the same developmental time-point http://
www.eurexpress.org. Smaller kidneys were evident in
Irs2-/- mice as early as postnatal day 5 (Fig. 2, 3), and kid-
ney-to-body weight ratio increased more rapidly between
postnatal day 5 and 12 in Irs2-/- mice compared to wild-
type, suggestive of catch-up growth in these animals (Fig.
3C). However, this increased rate of growth was not sus-
tained, and the kidney size defect did not recover as Irs2-/
- mice aged. Interestingly, it has been reported that kidney
and brain from Irs1-/-  mice exhibited proportionately
smaller weight reductions than the decrease in body
weight [35], as opposed to larger kidney/organ-to-body
weight ratio reduction observed in Irs2-/- mice. These
data emphasise the predominant role of IRS2 rather that
IRS1 in determining the growth of organs such as kidney
and brain.
Despite decreased kidney size in Irs2-/- mice, no major
morphological changes or reduction in nephron density
were detected, apart from slight compensatory glomeru-
lar hypertrophy. These results add to previous knockout
studies which demonstrated that insulin/IGF-1 signalling
pathway is not essential for renal morphogenesis, but
may be important for overall organ growth [13-15].
The kidney-specific upregulation of PKBβ/Akt2 in Irs2-
/- mice is interesting based on the overall similarity of
PKB/Akt isoforms, and previous data demonstrating a
degree of redundancy within the PKB/Akt family [36].
Mice lacking Rictor, a key element of the TORC2 complex
shown to phosphorylate PKB/Akt on Ser473 [37],
develop increased organ size, including kidney [38]. The
higher basal level of Ser473 phosphorylation seen in Irs2-
/- kidney suggests that higher TORC2 activity may con-
tribute to reduced kidney size in the absence of IRS2.
Experiments carried out by Zheng and colleagues identi-
fied that deletion of Irs2  attenuated insulin stimulated
bicarbonate absorption in isolated renal proximal tubules
[24]. Of note, these authors detected a decrease in PKB/
Akt phosphorylation on Ser473 with no apparent change
in PKB/Akt expression in kidney cortex of Irs2-/- mice
(Fig. 6A, C[24]). The divergence between these observa-
tions and our data presented here may be explained by
the fact that our study examined whole kidney lysates
rather than isolated, cultured renal cortex slices. In con-
trast to Zheng et al who examined Ser473 phosphoryla-
tion alone, the increase in PKB/Akt phosphorylation was
mainly detected on Thr308 in our experiments, and was
supported by increased GSK3β phosphorylation on Ser9
(Fig. 6, 7).
The specific increase in PKBβ/Akt2 protein (but not
mRNA) suggests increased translation of PKBβ/Akt2
mRNA, or that posttranslational processes leading to
PKBβ/Akt2 degradation are absent in the Irs2-/- kidney.
This novel finding also suggests that this process is spe-
cific for the PKBβ/Akt2 isoform. This increase in expres-
sion, together with increased PKB/Akt phosphorlyation
in the basal state may represent a compensatory mecha-
nism resulting from the loss of IRS2, to enhance growth
factor signalling in an effort to overcome defects in kid-
ney growth during development. Importantly, these data
imply that, contrary to the predicted cellular effects, loss
of IRS2 somehow enhances, rather than inhibits PKB/Akt
activation in the kidney. The precise molecular conse-
quences of Irs2  deletion in kidney cells remain to be
determined.
GSK3β is directly inactivated downstream of PKB/Akt
via phosphorylation on Ser9 [39,40]. Hyperphosphoryla-
tion of GSK3β was detected in Irs2-/- kidney but not in
liver or brain (Fig. 7). The "laddering" of GSK3β bands
reactive with the phospho-Ser9 antibody, together with a
decrease in the intensity of the GSK3β band at 47 kDa
(c.f. Fig. 7B) suggest that deletion of Irs2 causes PKB/Akt
phosphorylation-dependent decreases in GSK3β activity.
The accumulation of β-catenin (a GSK3β target) in the
kidney of Irs2-/- mice (Fig 7B, C) suggests that increased
phosphorylation of GSK3β leads to reduced GSK3β
kinase activity in the kidney, facilitating β-catenin accu-
mulation. This increase in β-catenin was not detected in
other tissues; again suggesting that defects in PKB/Akt/
GSK3β/β-catenin pathway is kidney specific in Irs2-/-
mice. Active β-catenin binds to the TCF/Lef family of
transcription factors [41] and serves as a co-activator to
stimulate the transcription of genes such as cyclin D1 and
c-myc [42,43], which drive cell proliferation. However,
protein levels of these β-catenin targets were not signifi-
cantly altered in Irs2-/- kidney versus controls (Fig. 7D).
Thus, increased cellular β-catenin levels do not appear to
be sufficient to increase protein targets in Irs2-/- kidney. It
remains to be determined if changes in β-catenin levels
alter its transcriptional activity during a period of defec-
tive embryonic kidney growth during development. Sig-
nificantly, insulin-stimulated PKB/Akt activation was not
decreased in Irs2-/- kidney at 5-6 wk (Fig. 6), and no
changes in basal PKB/Akt/GSK3β signalling were
detected in 5-6 wk Irs2-/- liver, where profound insulin
resistance was previously reported (9). We therefore
hypothesise that signalling changes reported here occur
as a direct result of Irs2 deletion in kidney, and not as aCarew et al. BMC Developmental Biology 2010, 10:73
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result of insulin resistance. Analysis of PKB/Akt signal-
ling at earlier time-points will help clarify these issues.
Several studies have clearly established that Hippo/
Mst1 pathway is critically involved in regulating organ
growth [30-32]. In mammals, the Mst1/LATS/Mob1/YAP
pathway plays a key role in restricting organ size by con-
trolling both cell proliferation and apoptosis [44-46]. The
final component of this pathway, YAP [47], is a potent
growth promoter, and overexpression of YAP in the liver
leads to organ enlargement [30,31]. YAP is inhibited by
the Hippo pathway via phosphorylation on Ser127, lead-
ing to its cytoplasmic translocation and retention [32].
YAP levels were markedly elevated in Irs2-/- kidney com-
pared to wild-type controls (Fig. 8A, B) Even though lev-
els of YAP were higher in Irs2-/- kidney, an increase in
YAP phosphorylation on Ser127 was also evident, sug-
gesting that immediate inactivation and nuclear export of
YAP may occur in Irs2-/- kidney cells, preventing
increased kidney growth. Preliminary data from our labo-
ratory suggests that levels of active Mst1, the upstream
kinase responsible for YAP phosphorylation on Ser127,
are also elevated in Irs2-/- kidney. Consistent with these
findings, protein levels of YAP downstream targets, E-
cadherin and survivin did not change significantly in Irs2-
/- kidney (data not shown). Therefore, similar to increased
β-catenin, the accumulation of YAP in adult kidney may
represent a compensatory mechanism for reduced kidney
size in Irs2-/-  mice. Ultimately, this compensatory
response is ineffective due to rapid Ser127 phosphoryla-
tion and therefore inactivation of YAP. Thus, we hypothe-
sise that reduced kidney size in Irs2-/- may trigger
changes in GSK3β and YAP signalling that ultimately fail
to overcome the growth defect in kidney.
Conclusions
In summary, we have established that mice lacking Irs2
display defects in kidney growth and PKB/Akt/GSK3β
signalling. It is clear that the integration of many signal-
ling pathways is required to regulate normal organ devel-
opment. Irs2  gene deletion results in decreased kidney
size and our observations suggest that specific signalling
changes in the PKB/Akt and YAP pathway occur in Irs2-/
- kidney . F ut ur e e xperimen ts will strive t o iden tify the
organ-specific growth control pathways that are relevant
to kidney development in the Irs2-/- mouse.
Methods
Experimental Animals
All mouse experiments were carried out in accordance
with the European Communities Council Directive (86/
609/EEC). All mouse handling was performed by licensed
technicians in the University College Dublin Biomedical
Facility and was performed with the appropriate govern-
mental and institutional ethical and legal approval and
licenses. Experimental animals were generated by cross-
ing Irs2+/- mice on a mixed genetic background (C57Bl/6
× 129sv). Genotyping was performed using DNA
extracted from ear punches as described [9]. Anaesthesia
and perioperative analgesia were used to maintain animal
well-being throughout the experiments.
In vivo manipulations
All biochemical analysis was carried out according to
Animal Models of Diabetic Complications Consortium,
http://www.amdcc.org. Body weight was assessed
biweekly until time of harvest. For insulin injections,
groups of Irs2+/+ and Irs2-/- mice were starved overnight
and injected intraperitoneally (i.p.) with 5 U human insu-
lin (Humulin S, Eli Lilly and Co.) or saline vehicle for 30
min, after which mice were sacrificed by cervical disloca-
tion and tissues harvested.
Tissue/sample preparation
The left kidney was ligated, removed and snap-frozen for
protein and RNA extraction. Images were captured by
thawing whole kidneys from both wild-type and Irs2-/-
mice (stored in RNAlater) and photographing on a glass
slide. Perfusion-fixation of the right kidney was per-
formed using non-fixative sterile normal saline (pH 7.4)
for 5 min, followed by 4% (w/v) paraformaldehyde (pH
7.4) for 5 min. The perfused right kidney was then
removed and submersed in 4% paraformaldehyde for 24 h
at RT. Kidneys were then paraffin embedded, cut at 3 μm
thickness and stained with haematoxylin eosin staining,
Masson's Trichrome, periodic acid-Schiff and Picrosirius
Red. Slides were scanned at 40 × magnification using a
ScanScope XT slide scanner (Aperio Technologies).
Stained sections were scored independently (single
blinded) by pathologists at the Department of Pathology,
University Medical Center Utrecht, Netherlands. For cal-
culation of glomerular number, each kidney was divided
in 4 parts of equal thickness, of which the central two sec-
tions were embedded on successive non-adjacent cut-
surfaces. Regions of the renal cortex were selected and
the number of glomeruli counted in each square. This
was repeated for 3 sections per kidney in 3 mice from 5-6
wk male Irs2+/+ and Irs2-/- groups. Glomeruli number was
then normalised to sectional area in each group.
IRS2/IRS1 RNA measurements
Total RNA was extracted from cells and mouse tissues
using Trizol (R) Reagent from Invitrogen. RNA from tis-
sues was further purified using RNeasy columns (Qia-
gen). Reverse transcription reactions were performed
using 1 μg of RNA and Superscript™ II (Invitrogen). One
μl of synthesised cDNA was then used for semi-qauntita-
tive and TaqMan PCR to amplifiy either IRS1 or IRS2.Carew et al. BMC Developmental Biology 2010, 10:73
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Oligonucleotides for semiquantitative PCR were as
described (Withers et al 1998) and for TaqMan were pur-
chased from Applied Biosystems (IRS2,
Mm03038438_m1; IRS1 Mm00439720_s1). 18S was run
as a normalisation control and the ΔΔCt method was
used to calculate fold-change in RNA levels for each gene.
Protein extraction, immmunoblotting and 
immunoprecipitation
Both kidney tissue and cultured cells were lysed in RIPA
buffer exactly as previously described [29]. Antibodies at
the following dilutions were used: IRS-2 (1:500 generated
in-house, Prof. Morris White), IRS-2 (Millipore, used for
immunoprecipitation), polyclonal pAkt Ser473 (1:1000,
Cell Signaling), pAkt Thr 308 (1:1000, Cell Signaling),
pGSK-3β Ser9 (1:1000, Cell Signaling), total GSK-3β
(1:1000, Cell Signaling), β-catenin (1:1000, BD Biosci-
ences), total YAP (1:1000, Cell Signaling), pYAP Ser127
(1:1000, Cell Signaling), isoform specific PKB/Akt anti-
bodies PKBα (1:500), PKBβ (1:500), PKBγ (1:5000) were a
generous gift from Dr. Brian Hemmings, Friedrich Mie-
scher Institute, Basel, Switzerland, total PKB/Akt (1:1000,
Cell Signaling), GAPDH (1:5000, Cell Signaling), β-actin
(1:25,000, Sigma). Reactive bands were revealed using
HRP-coupled secondary antibodies and enhanced chemi-
luminescence reagents (Santa Cruz Biotechnology) and
X-ray film.
Immunoprecipitation was carried out to detect IRS2
expression in the kidney. Kidneys were lysed as described
above. Supernatants containing 1 mg of protein lysate
were pre-cleared with 20 μl of a 50% slurry of protein-A/
G-Sepharose (Pierce) for 60 min at 4°C and incubated
overnight with 5 μl (5 μg) anti-IRS2 antibody (Millipore).
Immune complexes were collected with 20 μl of a 50%
slurry of protein-A/G-Sepharose and resolved on a 7.5%
SDS-PAGE as described above.
Statistical analysis
All data were expressed as mean +/- SEM. Statistical
analysis was carried out using InStat software. Student's
unpaired t-test or analysis of variance (ANOVA) with
post hoc Tukey-Kramer Multiple Comparison test was
used, with a difference of p < 0.05 considered significant.
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